Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.8 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |